Seizure resistance without parkinsonism in aged mice after tau reduction

Neurobiology of Aging

Volumn 35, Issue 11, 2014, Pages 2617-2624

  Li, Zhiyong ^a   Hall, Alicia M ^a   Kelinske, Mark ^b   Roberson, Erik D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Epilepsy; Excitability; Microtubule; Parkinsonism; Seizure; Tau

Indexed keywords

DOPAMINE; IRON; TAU PROTEIN;

AGED; ARTICLE; BIOACCUMULATION; BRAIN WEIGHT; CONTROLLED STUDY; DISEASE RESISTANCE; DISEASE SEVERITY; EXECUTIVE FUNCTION; FEMALE; HYPERACTIVITY; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PARKINSONISM; PHENOTYPE; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TARGETING; SEIZURE; AGING; ALZHEIMER DISEASE; ANIMAL; C57BL MOUSE; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOLECULARLY TARGETED THERAPY; SEIZURES;

AGING; ALZHEIMER DISEASE; ANIMALS; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR TARGETED THERAPY; PARKINSONIAN DISORDERS; SEIZURES; TAU PROTEINS;

EID: 84922887918     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.05.001     Document Type: Article

References (22)

1. Andrews-Zwilling Y., Bien-Ly N., Xu Q., Li G., Bernardo A., Yoon S.Y., Zwilling D., Yan T.X., Chen L., Huang Y. Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J.Neurosci. 2010, 30:13707-13717.
2. Boyd J.D., Jang H., Shepherd K.R., Faherty C., Slack S., Jiao Y., Smeyne R.J. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta. Brain Res. 2007, 1175:107-116.
3. Dawson H.N., Ferreira A., Eyster M.V., Ghoshal N., Binder L.I., Vitek M.P. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J.Cell Sci. 2001, 114:1179-1187.
4. Devos S.L., Goncharoff D.K., Chen G., Kebodeaux C.S., Yamada K., Stewart F.R., Schuler D.R., Maloney S.E., Wozniak D.F., Rigo F., Bennett C.F., Cirrito J.R., Holtzman D.M., Miller T.M. Antisense reduction of tau in adult mice protects against seizures. J.Neurosci. 2013, 33:12887-12897.
5. Holth J.K., Bomben V.C., Reed J.G., Inoue T., Younkin L., Younkin S.G., Pautler R.G., Botas J., Noebels J.L. Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy. J.Neurosci. 2013, 33:1651-1659.
6. Ikegami S., Harada A., Hirokawa N. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice. Neurosci. Lett. 2000, 279:129-132.
7. Ittner L.M., Ke Y.D., Delerue F., Bi M., Gladbach A., van Eersel J., Wölfing H., Chieng B.C., Christie M.J., Napier I.A., Eckert A., Staufenbiel M., Hardeman E., Götz J. Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models. Cell 2010, 142:387-397.
8. Kimura T., Whitcomb D.J., Jo J., Regan P., Piers T., Heo S., Brown C., Hashikawa T., Murayama M., Seok H., Sotiropoulos I., Kim E., Collingridge G.L., Takashima A., Cho K. Microtubule-associated protein tau is essential for long-term depression in the hippocampus. Philos. Trans. R. Soc. Lond. 2014, 369:20130144.
9. Lei P., Ayton S., Finkelstein D.I., Spoerri L., Ciccotosto G.D., Wright D.K., Wong B.X., Adlard P.A., Cherny R.A., Lam L.Q., Roberts B.R., Volitakis I., Egan G.F., McLean C.A., Cappai R., Duce J.A., Bush A.I. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 2012, 18:291-295.
10. Leroy K., Ando K., Laporte V., Dedecker R., Suain V., Authelet M., Héraud C., Pierrot N., Yilmaz Z., Octave J.N., Brion J.P. Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice. Am. J. Pathol. 2012, 181:1928-1940.
11. Loscher W., Honack D., Fassbender C.P., Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res. 1991, 8:171-189.
12. Meilandt W.J., Yu G.Q., Chin J., Roberson E.D., Palop J.J., Wu T., Scearce-Levie K., Mucke L. Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease. J.Neurosci. 2008, 28:5007-5017.
13. Morris M., Hamto P., Adame A., Devidze N., Masliah E., Mucke L. Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice. Neurobiol. Aging 2013, 34:1523-1529.
14. Musumeci M., Maccari S., Sestili P., Massimi A., Corritore E., Marano G., Catalano L. The C57BL/6 genetic background confers cardioprotection in iron-overloaded mice. Blood Transfus. 2013, 11:88-93.
15. Nussbaum J.M., Schilling S., Cynis H., Silva A., Swanson E., Wangsanut T., Tayler K., Wiltgen B., Hatami A., Ronicke R., Reymann K., Hutter-Paier B., Alexandru A., Jagla W., Graubner S., Glabe C.G., Demuth H.U., Bloom G.S. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature 2012, 485:651-655.
16. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., Yoo J., Ho K.O., Yu G.-Q., Kreitzer A., Finkbeiner S., Noebels J.L., Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55:697-711.
17. Palop J.J., Mucke L. Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010, 13:812-818.
18. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
19. Roberson E.D., Halabisky B., Yoo J.W., Yao J., Chin J., Yan F., Wu T., Hamto P., Devidze N., Yu G.Q., Palop J.J., Noebels J.L., Mucke L. Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J.Neurosci. 2011, 31:700-711.
20. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., Gerstein H., Yu G.-Q., Mucke L. Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model. Science 2007, 316:750-754.
21. Schauwecker P.E. Strain differences in seizure-induced cell death following pilocarpine-induced status epilepticus. Neurobiol. Dis. 2012, 45:297-304.
22. Tucker K.L., Meyer M., Barde Y.A. Neurotrophins are required for nerve growth during development. Nat. Neurosci. 2001, 4:29-37.